Zyagnum AG is a biotechnology company with the aim of making serious diseases visible, and therefore treatable, at the earliest possible stage. We are convinced that many diseases can be better treated and cured the earlier they are discovered. We therefore believe that the key to curing the major unsolved medical problems of our time lies in early detection diagnostics.
Since 2007, we have been working on the development of technologies with which these widespread diseases can be detected earlier. The result of this intensive development period is our proprietary EDIM® Technology.
With around 50 employees at the Darmstadt site and numerous close business partners in Germany and abroad, we are now working on the implementation of our ideas for diagnostics.
The core of our prevention work is our diagnostics laboratory. Our diagnostic focus is on a specially developed technology in the field of immuno-oncological flow cytometry.